Studies intended to demonstrate a slowing of the rate of degeneration, modeled upon clinical trials for ALS, are problematic.
This paper describes a method for modeling clinical trial workflow in UML and standardizing these workflow diagrams through a UML profile.
Not surprisingly, MSCs are currently tested in various animal models and clinical trials for lung and brain regeneration [103 105].
The major context focuses on a few small molecules toward the pathogenesis available in animal models and clinical trials for the treatment of DN.
Gene vectors with an untargeted insertion profile have been explored in preclinical models and clinical trials for the transfer of potentially therapeutic genetic information into somatic cells that have a high replicative potential.
As such, this provides a unique model for chemoprevention trials for high-risk premalignant breast lesions.
The parameter θ ij =θ ji ∈[0, 1] gives the probability of an undirected, unweighted edge between any pair of vertices u∈ i and v∈ j, modeled as independent Bernoulli trials for each pair.
With respect to intervention models, various trials analysed for this review used the transtheoretical model of change with positive results; however, reviews of literature have not arrived at a clear conclusion about the effectiveness of this model.
Most innate mucosal adjuvants are evaluated on animal models, requiring further human trials for safety and efficacy of these potent molecules.
In light of this, many researchers have called for the development of large animal models to test preclinical trials for CNS disease, including SCI [1], [8], [9], [10].
